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Objective: To establish the effect of exercise therapy in patients with intermittent claudication and to identifiy outcome 
predictors for exercise training. 
Design: A methodological study of randomised clinical trials. 
Methods: A quality assessment ofall eligible studies was petformed, using a list of methodological criteria. A weighing 
scale for the criteria was developed, based on four main categories: tudy population, intervention, outcome variables and 
data presentation~analysis. 
Results: Ten studies were included in the analysis. Seven randomised clinical trials had a methodological score of 60 or 
more points (maximum 100), and were considered to be of good quality. The mean of the methodological score was 62.5 
(s.D. 8.5). hnprovement in pain-free~maximum walking distance~time ranged from 28-210% (Yc 105, s.D. 55.8). Only 
one study evaluated outcome predictors for exercise therapy. 
Conclusions: All studies reported a positive effect of exercise therapy on walking distance in patients with intermittent 
claudication, but no predictive factors were clearly identified. Future research efforts hould focus on improving the 
quality of clinical research for patients with intermittent claudication and developing optimal rehabilitation programs. 
Key Words: Intermittent claudication; Exercise therapy; Meta-analysis; Randomised Clinical Trial; Methodology; Review. 
Introduction 
The natural history of claudication is benign in the 
majority of patients. Few patients progress to rest pain 
or critical ischaemia, and most patients experience 
stabilisation or some improvement of lower extremity 
symptoms. ~'2 Knowledge of the course of intermittent 
claudication is important to determine the appropriate 
treatment, g A conservative approach of patients with 
claudication has been recommended, usually advising 
the patient o exercise regularly and to stop smoking. 4 
Exercise therapy - including walking exercise - im- 
proves the (pain-free) walking distance. B'6 The under- 
lying physiological mechanisms which could explain 
the effects are multifactorial. 7 
Vascular surgery or percutaneous transluminal an- 
gioplasty (PTA) is indicated in patients with disabling 
claudication, interfering with professional or basic 
* Please address all correspondence to: Prof. R. A. B. Oostendorp, 
Dutch National Institute of Allied Health Professions, P.O. Box 1161, 
3800 BD Arnersfoort, The Netherlands. 
daily activities or in patients with rest pain or ul- 
cerationY The conservative and operative treatment 
of intermittent claudication has been the subject of 
considerable controversy. Management decisions are 
based on an assessment of the impact of the disease 
on a patient's quality of life balanced against the 
possible benefits and risks of vascular interventions. 
It has been suggested that the outcome measures 
should include quality of life. 1° Identifying predictive 
factors could help in the selection of patients who will 
benefit he most from structured exercise therapy. Few 
studies have reported on possible predictive factors 
of the outcome of exercise therapy. ~1-~4 
This paper presents the findings of a systematic 
review of randomised, clinical trials designed to ac- 
complish the following goals: (i) to provide an ad- 
equate assessment of the methodological quality of 
randomised clinical trials (RCTs) for exercise therapy in 
patients with intermittent claudication; (ii) to identify 
predictors of outcome of exercise therapy; (iii) to evalu- 
ate the effect of exercise therapy in patients with 
intermittent claudication. 
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Methods 
The Medline database and the database of the Dutch 
National Institute of Allied Health Professions were 
used to identify relevant studies. In addition, a com- 
puterised literature search using Excerpta Medica and 
Physiotherapy Index was conducted based on the 
key words "intermittent claudication, arterial occlusive 
disease, peripheral vascular disease" and "walking, 
physical education, training, gymnastics, exercises, ex- 
ercise therapy, running"; in combination with "review, 
meta-analysis or clinical trials". Next a cross-reference 
search was conducted on the bibliography of each 
article and key review articles, and information was 
obtained from specialists in the field. 
For a study to be included the following criteria had 
to be met: (i) the study should be a randomised clinical 
trial (RCT), and (ii) published in English, German, 
French or Dutch, (iii) outcome measures hould be 
walking capacity as assessed on (iv) a treadmill. Studies 
selected for the present analysis included randomised 
clinical trials with untreated controls, including placebo 
drugs and other interventional treatments. 
To ensure objectivity in all phases of our analysis a
study protocol was developed. The literature search 
was conducted by two investigators (S.H., R.O.), not 
the reviewers. Eligible studies were subjected to a 
blinded qualitative assessment by two independent 
reviewers (G.R., J. B.). One is a physician who works 
in the field of cardiac and vascular rehabilitation, 
the other is a registered physical therapist. To guard 
against assessor bias we decided to blind the author 
and setting of the study. Also the name of the journal, 
date of publication and reference list were blinded. 
Preceding the blinded review of the articles by the 
two reviewers, a list of methodological criteria was 
developed. The criteria re based on generally accepted 
principles of intervention research and refer to various 
aspects of study population, description of in- 
terventions, outcome measures, and data presentation 
and analysis. ~5 This list with criteria was adopted from 
Chalmers ~6 and modified by Bouter. 17 Criteria specific 
to the study population were incorporated. A weight 
was attached to each criterion, resulting in a maximum 
score of 100 points for each study. Table 1 shows the 
criteria used for assessing the methodological quality 
of the studies (full description of the criteria is available 
on request). The studies were rated independently b
the two reviewers. Disagreements between the two 
reviewers were resolved by consensus or by consulting 
a third researcher who acted as referee. A RCT was 
(arbitrarily) considered to be of good quality if the 
methodological score was 60 points or more, and of 
poor quality if the methodological score was less than 
60 points. 
A second list, specific for this patient group, was also 
developed. This list included patients' characteristics, 
baseline physiological data, description of therapeutic 
intervention, the role of the physical therapist, and 
clinically relevant outcome measures. 
Results 
Eighty-two (82) studies were identified. Two authors 
(S.H., R.O.), not the reviewers, excluded 61 articles, 
leaving 21 that seemed suitable for analysis by the 
reviewers (G.R., J.B.) 5'18-37 Also, two review articles and 
one meta-analysis were identified. 6'3s'39 These articles 
were given to the reviewers after the completion of 
their analysis in order not to be influenced by these 
studies. A total of 10 studies met the inclusion 
criteria. 5'18-26 For different reasons 11 studies were ex- 
cluded. 27-37 In five s tud ies  28'29'34'35'37 the patients were 
not randomised; two studies 34'36 did not report on 
the outcome variable of interest: pain-free walking 
distance or time; four studies 27'3°-32 were studies pub- 
lished in different journals. 
Table 2 lists the studies included in this review. The 
10 randomised clinical trials were conducted between 
1966 and 1996. Most of the studies had a small sample 
size. Only one study 21 had 25 patients enrolled, the 
remaining studies less than 20. Five of the documents 
were presumed to be true RCTs, having an untreated 
control groupY 8'19'23'25 Two studies reported on the 
same study population, although different outcome 
variables were presented and discussed. 25'26 Both stud- 
ies were analysed in this review. One of the studies 
recently evaluated the effects of exercise training on 
daily activities. 26The training program improved func- 
tional status during daily activities, with 24 weeks 
being more effective than 12. Eight studies, one du- 
plicate study, 25 scored 60 or more points and were 
considered to be of good quality. 18-23'25'26 The median 
score was 61 and the range 47-75 (£ 62.5; S.D. 8.5). 
The most prevalent shortcomings appeared to be the 
heterogeneity of the study population, the small num- 
ber of patients, the lack of information on compliance, 
the absence of blinding of researcher or statistician, 
and lack of adequate follow-up. 
Table 3 is a summary of the demographic and clinical 
characteristics of the patients in the exercise training 
groups. Most trials studied men between the ages of 
60 and 76. In six s tud ies  2°-23'25'26 a high percentage 
(58-93%) of patients was reported who had continued 
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Table 1. Criteria list for the methodological assessment of randomised clinical trials of exercise 
therapy in patients with intermittent claudication. 
Criteria Weight 
Study population 
A Homogeneity 4 
B Comparibility of relevant baseline characteristics* 10 
C Randomisation procedure adequate 4 
D Drop-outs described for each study group separately 4 
E <20% loss to follow-up 2 
<10% loss to follow-up 2 
F >10 subjects in the smaller group 2 
>20 subjects in the smallest group 2 
Interventions 
G Interventions i cluded In protocol and described 
H Pragmatic study 
I Co-h~terventions avoided 
J Placebo-controlled 
K Mentioning good qualification ofsupervising therapist 
10 
7 
5 
5 
Effect measurement 
L Patients blinded 5 
M Outcome measures relevant** 10 
N Blinded outcome assessments 10 
O Follow-up eriod adequate 5 
Data Presentation a d analysis 
P Intention-to-treat analysis 5 
Q Frequencies of most important outcomes presented for each treatment 5 
group 
100 Total methodological score 
30 
30 
30 
10 
100 
* This criterion was scored with great caution, because opinions vary on which factors are prog- 
nostically relevant. Prognostic factors used: age, sex, duration of disease, walking distance, ankle 
brachial pressure index, level of arterial stenosis, moking, cardiac disease, diabetes, hypertension. 
** Outcome measures used: walking distance/time assessed on a treadmill, ankle brachial pressure 
index and other diagnostic procedures, functional status/quality oflife. 
smoking after the formal exercise program had started. 
Only one study 2° had a smoking cessation program in 
addition to exercise training. The duration of clinical 
symptoms was in most studies more than 1 year. 
No information was given about the duration of the 
disease in two studies. 22'23 The severity of peripheral 
artery disease, in terms of a resting ankle-brachial 
pressure index (ABPI), was reported in seven 
studies. 1s'2~-26 In some of the studies the resting ABPI 
and the post-exercise ABPI was given. 23-27 In four 
studies '2°-22 angiography was used to determine the 
exact location of occlusive disease. Baseline walking 
distarice varied considerably, depending on the tread- 
mill test protocol. Table 4 gives specific information 
on the interventions and the results of the studies. The 
exercise programs how a wide variation in intensity, 
frequency and duration. Also the type of exercises 
varied: in five studies 19'20'23'25'26 walking exercises were 
performed on a treadmill, supervised training was 
given in all  except one study 5 and in most of the 
studies patients were encouraged to exercise at home. 
The studies did not all use the same outcome meas- 
ure. Improved walking performance was assessed as 
improvement in pain-free or maximum walking dis- 
tance or walking time. The overall improvement in 
walking distance or walking time has been adopted 
from the articles, or has been calculated from the data 
or figures in the studies. Percentage improvement in
walking distance/time ranged from 28-210% (,~ 105; 
S.D. 55.8). All studies show beneficial effects of exercise 
therapy on walking capacity in patients with in- 
termittent claudication. Only one study evaluated out- 
come predictors for exercise therapy. 21 In this study the 
possible ffects of exercises on walking performance in
patients who had reconstructive ascular surgery were 
investigated. The walking performance was improved 
in the three treatment groups. Age, sex, a history of 
myocardial ischaemic disease, diabetes and level of 
Eur J Vasc Enclovasc Surg Vol 15, January 1998 
Exerc i se  Therapy  fo r  In termi t tent  C laud icat ion  39  
O 
r~ 
O 
°~ 
r,..) 
H 
8 
o ~ ~ o ~[--~ 
I 
© 
2 
Ct, 
O 
;~-1 b... oo 
tO D 
tO°  G) ~¢q 
o ~ oo 
.~ ~ o 
~-~> 
0 ,~  0 0 0 
O 
~ (3" , °  ~ ~ 
,.o ~ tN 
~" ~ a-, ; o', .~ 
:0 ~ ~ ~;~,~. ~ r ~ 
~-~ 
~-o  
b~ 
~-~ 
O-~ 
b'~ 
~ O ~-~ 
~.~ 
o~ 
"d 
0 
> 
31 
< 
0 
g+~ 
r~ 
U3 
;>. ,~  
< +1 
~J 
>,  
O 
;.T., 
~v~'~ v ~a~ ~-~ 
"3 
0 
~.o  
o o o 
+1 +l +1 31 31 31 +1 31 31 
• " d d d d d d d  
0303 O~ O0 
I I I 0" ,0" ,  '.0 tO  I '.0 
b ,  
I ~'% +1 +1 +1 +1 ~'~ I 
oo,~ ,.q. ~ 
~-. ~ ~ ~. .~"  
~++ 
"~=~4 
~ O ~ 
>~N.  
~.~ 
rj "~ 
~ m 
"~ ~O 
~N 
.~  
O 
8 
5 
O 
-~.~ ~ 
d 
Eur J Vasc Endovasc Surg Vol 15, January 1998 
40 G.G.  Robeer  et al. 
'-~ "a 
o 
'~  l:Z. 
o 
0 
• = -= .~ 
ca 
ca 
~ ~ ~.~- 
-a > o 
~ ~ ~ 
+ ] +1+1 ÷+++ + + +÷÷ 
~j 
.~ 
~R 
+1 +1 
"~. 0 ~> ~ o~ o < 
..c ~ {a ~ .,-* ~ ~ ~ ~-~ 
• ~ .5 ~ ~ o 
++ +++++~ 
,a  o u x o 
-t-+ 
.~ 
~ ~ ~ ° 
~ ~ ~ ~'~ ~ o 
<~ 
q~ 
×~ 
03 U er) ~ 
© 0 
; '~  
ca 
~~ ~ 
~ ~ ~ ~ . 
t-.  
-t- 
~ a 
9 
II 
D 
c~ 
.5 
JI 
E~ 
F* 
cq 
~3 
~PD 
ca 
Eur J Vasc Endovasc Surg Vol 15, January 1998 
Exercise Therapy for Intermittent Claudication 41 
stenosis were not significantly correlated to increases 
in walking distance. 
Discussion 
This review demonstrates the large variety in 
methodological quality of randomised clinical trials 
for exercise therapy in patients with intermittent clau- 
dication. Most studies lack a clear description of an 
adequate randomisation procedure. The trials included 
in our review had a small sample size. For this reason, 
many studies lack statistical power to detect potentially 
important differences in effects between the in- 
terventions. Another problem with smaller sample 
sizes is that prognostic variables may not be equally 
distributed between the study groups after ran- 
domization. These limitations can be addressed by 
adding the methodological quality of the RCTs in a 
systematic review (meta-analysis), in order to come to 
valid conclusions. 48-5~ We have refrained from stat- 
istical pooling because of the generally low methodo- 
logical quality of the trials and the heterogeinity of 
the study groups and the outcome measures, follow- 
up time and (reference) treatments. 
The assessment orinfluence of compliance was given 
little attention in most trials. In this review only two 
studies reported on compliance. 21'22 To make a valid 
interpretation of the outcome of a study, however, this 
information may be very important. Two studies 21'26 
had drop-outs, which were not accounted for. This 
could have influenced the main outcome measures. 
Most studies reported short-term effects only. Long- 
term effects (more than 6 months after randomisation) 
were rarely provided. 21 Despite the positive con- 
clusions reported by the investigators, there were 
many differences in baseline characteristics, e.g. se- 
verity of claudication, and the analysis and reporting 
of outcome variables. The question as to which patients 
benefit most is therefore difficult to answer. 
Few studies have addressed the identification of 
predictive factors for the outcome of exercise therapy in 
patients with intermittent claudication. In our analysis 
one study 21 evaluated predictors of the success of 
exercise training. This study by Lundgren showed 
that age, sex, history of myocardial ischaemic disease, 
diabetes and level of stenosis had no influence on the 
effect of training. In the literature a wide variety of 
factors have been studied: risk factors, physiological, 
metabolic, neuro-endocrine and haemodynamic vari- 
ables, and cognitive factors. The clinical outcome of 
patients who follow an exercise program seems to 
be positively influenced by smoking cessation) 1'4547 
Jonason et al. ~ concluded from their study that the 
possibility of predicting the effect of training on the 
walking capacity in the individual patient with in- 
termittent claudication was limited. In this study and 
the study of Ekroth et al. 48 there was no significant 
difference found between the effect of exercises on 
walking distances in patients with single or multiple 
(combined aorto-iliac and femoropopliteal) stenosis. 
This was in agreement with the findings of Lundgren 
et al. 21 Andriessen et al. 12 also concluded that it was 
not possible to predict which patients would benefit 
from an exercise program. Gardner and Poehlman, 39 
however, found age the only characteristic that sig- 
nificantly correlated with walking distance. Rosfors et 
al J  3 found cognitive factors, i.e. belief in training and 
motivation to participate, of major importance in pre- 
dicting functional effects of exercise training. 
Many studies about patients with intermittent clau- 
dication did not report on coexisting diseases (co- 
morbidity), or patients with coexisting diseases were 
excluded. Patients with claudication frequently have 
coexistent coronary artery disease (CAD) and are at 
a significantly higher risk of adverse cardiovascular 
events. 49 It has therefore been advised to use exercise 
stress testing for coronary artery disease to detect 
those particularly at risk from cardiac complications. 5° 
Few studies reported on cardiological evaluation of 
patients with intermittent claudication before entry in 
a formal exercise program. 48'5143 One study 53 reported 
poor results (p_< 0.05) after patients with CAD under- 
went exercise therapy. This is in line with the findings 
of Krause, 14 although angina pectoris in itself is not 
considered a contraindication to exercise therapy. 53 
Patients with diabetes have the same benefit from 
exercise therapy as other patients. 21'48'51 In our 
review comorbidity such as cardiac disease s'a2 and 
diabetes 19'22'24 were only mentioned in a few studies. 
All studies showed that (walking) exercises had a 
positive effect on walking capacity. An improvement 
of pain-free walking distance/time was calculated for 
the RCTs. Four of these studies showed an im- 
provement of at least 100% or more increase of pain- 
free and maximum walking distanceJ 8'19'22'23 However, 
the actual improvement in walking distance may not 
be clinically important. Hiatt et a/. 22 and Creasy et 
aL as both showed that initial improvement in walking 
performance improved further with additional ex- 
ercise periods. However, few studies reported lasting 
effects after the intended exercise program has been 
accomplished; 1"52-54 only one, in our analysis. 22 There 
have been other reviews of the efficacy of exercise 
therapy in patients with intermittent claudication. 
Gardner et al. 39 conducted a quantitative meta-analysis 
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in which the results of 21 trials were pooled statistically. 
In their study the methodological quality of the studies 
was not assessed. They demonstrated that the overall 
walking distance to the onset of pain and maximal 
claudication pain during treadmill testing increased 
by 120%-180% after exercise rehabilitation. In their 
opinion the optimal exercise program for improving 
claudication pain uses intermittent walking exercises 
to near-maximal pain, a minimum of three exercise 
sessions per week, a duration greater than 30 rain per 
session, and a program length greater than 6 months. 
From the trials studied in our systematic review it 
became clear that an optimal exerciseprogram for 
intermittent claudication does not exist. Only general 
recommendations can be given based on these studies. 
Also, little is known about the prognosis of the in- 
dividual patient, i.e. which patients may eventually 
need operation or angioplasty? Currently the in- 
dications and effects of surgical therapy for clau- 
dication are under debate. The optimal method of 
treatment interms of patient risk, benefit and costs, has 
not been established. 55-57 An international multicentre 
trial is investigating the effects of interventional ther- 
apy. ss 
The conclusion of this review is the same as other 
review articles6'38'39: that exercise therapy improves 
walking performance in patients with intermittent 
claudication. No optimal exercise therapy could be 
extracted from this review, leaving many questions 
unanswered. What is the optimal exercise therapy? 
(Frequency, type, mode, intensity and duration of non- 
supervised or supervised programs?) Will an im- 
proved performance translate into improved func- 
tional status, reduction in cardiovascular morbidity 
and mortality and, eventually, result in a decreased 
number of interventions? Are there any factors that 
predict he outcome of exercise therapy? Better defined 
guidelines are needed for exercise training of high- 
risk patients, such as those with angina pectoris. Also, 
prospective cost-effectiveness studies should be con- 
ducted. These studies should include evaluation of 
supervised vascular ehabilitation programs with re- 
gard to improvements in functional capacity, modi- 
fication of risk factors, long-term compliance, quality 
of life, and medical costs incurred. 
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